Showing results (171-180 of 3,013) with videos related to

Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|September 6, 2025
Thorough Physiological Assessment in Non-Culprit Vessels of Patients with Acute Myocardial Infarction: Is It a Required Action?Zining Chen, Yuxuan Zhang, Jiacheng Fang, et al.
Cardiovascular Drugs and Therapy|May 14, 2021
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 PatientsVincenzo Russo, Roberta Bottino, Antonello D'Andrea, et al.
Cardiovascular Drugs and Therapy|August 4, 2021
How to Use Statins in Secondary Prevention of Atherosclerotic Diseases: from the Beneficial Early Initiation to the Potentially Unfavorable DiscontinuationNikolaos P E Kadoglou, Marianna Stasinopoulou
Cardiovascular Drugs and Therapy|May 24, 2021
A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network PharmacologyZiling Mai, Huanqiang Li, Guanzhong Chen, et al.
Cardiovascular Drugs and Therapy|February 13, 2023
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure MyocardiumJorik H Amesz, Sanne J J Langmuur, Nina Epskamp, et al.
Cardiovascular Drugs and Therapy|August 10, 1999
Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive valueC S Apstein, L H Opie
Cardiovascular Drugs and Therapy|August 10, 1999
Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial DysfunctionJ D Schlaifer, G B Mancini, B J O'Neill, et al.
Cardiovascular Drugs and Therapy|June 18, 1999
Effect of trimetazidine on late potentials after acute myocardial infarctionR Ozdemir, C Tuncer, M Aladag, et al.
Cardiovascular Drugs and Therapy|February 25, 2000
Effect of low-dose aspirin on the markers of oxidative stressT Ristimäe, M Zilmer, K Zilmer, et al.
Cardiovascular Drugs and Therapy|February 25, 2000
How long can an escalation of dose override tolerance to the hypotensive efficacy of nitroglycerin infusion in coronary care patientsG Milicevic, V Goldner, B Vrhovac, et al.
Pageof 302